Meet our team
We have a multidisciplinary team comprised of entrepreneurs, scientists, and engineers with one goal in mind—pioneering science and continuously pushing the limits of what's possible to recreate organs in the lab.
ERIC BENNETT, CEO & Founder
Eric is a serial entrepreneur with expertise developing advanced technologies. Prior to Frontier Bio, he was the CTO at Aether, producing low-cost, feature-rich bioprinters. His extensive scientific background covers brain-computer interfacing, optogenetics, microfluidics, DNA assembly, in addition to bioprinting. He earned a Master's degree in Biomedical Engineering, with his research centering on the use of optogenetics and brain-computer interfacing to study and mitigate neural disorders. Eric is committed to creating transformative technologies that push the frontier of what's possible.
VICTORIA-ELISABETH GRUBER, Head of Translational Research
Victoria is an expert in 3D cell culture models and neuropathology. Prior to joining Frontier Bio, she was a Postdoctoral Fellow at Harvard Medical School where she researched the genetics of tuberous sclerosis complex. She has a doctorate in Clinical Neurosciences and a master’s degree in Biochemistry. In 2022, she received the Herbert-Reissner Prize for her outstanding work in epilepsy research. Currently, she leads the development of neural technologies at Frontier Bio.
JONARD VALDOZ, Head of In Vitro Development
Jon is an entrepreneurial scientist. Early in his career, he represented the Philippines as an official delegate to two international events for multinational relations and science. Prior to Frontier Bio, Jon was a research scientist at MilliporeSigma where he worked on biopharma applications of various organoid and cell-based technologies. He has a doctorate in Biochemistry from BYU. Jon currently leads the company's efforts in lung bioprinting, corporate branding, marketing, and business operations.
SAM PASHNEH-TALA, Head of Vascular Engineering
Sam completed his PhD and fellowship at the University of Sheffield. His research focused on producing tissue-engineered blood vessels for clinical and in vitro applications, including collaborations with leading medical device and 3D printing companies. Prior to joining Frontier Bio, Sam ran a boutique consultancy firm for tissue engineering and advanced medical device design, working with industry and academic clients.